Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Delay Announces Delay in Annual Filings Under Covid-19 Duress

June 26, 2020


Burlington, Ontario – June 26, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the Ontario Securities Commission and other members of the Canadian Securities Administrators granted “Issuers” in the Canadian securities...

Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process

June 19, 2020


BURLINGTON, Ontario – June 19, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has filed a non-provisional patent with the USPTO for...

RAPID DOSE THERAPEUTICS Signs agreement with Leede Jones Gable to provide Financial Advisory Services and Announces Change to its Board of Directors

May 29, 2020


BURLINGTON, Ontario – May 29, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian Life Sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed an agreement with Leede Jones Gable to...

Rapid Dose Therapeutics Donates Quickstrip™ Vitamin B12 Nutraceutical Product to Community

April 2, 2020


Burlington, Ontario – April 2, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) in response to the COVID pandemic, recently made a donation to the Burlington Foodbank contributing over 16,000 QuickStrip™ Vitamin B12 product to distribute to those in need in...

Rapid Dose Therapeutics Announces Shipment Of Quickstrip™ Nutraceutical Products

March 31, 2020


Burlington, Ontario – March 31, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce that RDT has completed its first shipment of QuickStrip™ nutraceutical products to Peter Pan Brands. The QuickStrip™ nutraceutical product line will be distributed by...

Rapid Dose Therapeutics Announces Operational Changes

March 23, 2020


Burlington, Ontario – March 23, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that operations at its Burlington, Ontario facility have been curtailed due to a number of reasons including the recent dramatic drop in North American stock markets, the...

Rapid Dose Therapeutics Announces Investment Agreement With Institutional Investor

March 5, 2020


Burlington, Ontario – March 5, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) today announced that it has entered into an agreement for a drawdown equity financing facility (the “Investment Agreement”) with a single institutional investor. Subject to its terms and...

Rapid Dose Therapeutics Announces Nutraceutical Reseller Agreement for Canada, United States and India

February 27, 2020


Burlington, Ontario – February 27, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce an Agreement with Perennial Brands, a DCM company, for the distribution and sale of nutraceutical oral dissolvable strip products in Canada, the United States...

Rapid Dose Therapeutics Announces Issuance of CRA Cannabis Licence and Board and Management Changes

February 21, 2020


Burlington, Ontario – February 21, 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce receipt of its Canada Revenue Agency (CRA) Cannabis Licence in February 2020, and now has obtained all approvals for cannabis processing and packaging for...

Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product

February 4, 2020


Burlington, Ontario – February , 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce the company has secured government funding of $400,000 from The National Research Council of Canada Industrial Research Assistance (NRC-IRAP), to support a project focused...

1 2 3 4 5